A lesson from Malignant Hyperthermia: Unmasking the Invisible Threat

Navigating Post-Acute MH

The aftermath of an MH episode requires diligent monitoring and care. Post-crisis, the patient should be placed in a closely-monitored setting for at least 24 hours. During this period, continuous or intermittent dantrolene administration is recommended, particularly in light of the common occurrence of MH recurrence within the first day post-event.

Once stabilized, patients should be thoroughly counseled regarding their MH history. Given the potential ramifications, emphasis should be on sharing this crucial medical history with all healthcare providers. Wearing a medic alert bracelet and flagging volatile anesthetics and succinylcholine as allergies in the electronic medical record can provide an additional safety net.

The ripple effects of an MH diagnosis extend to the patient's family. Genetic links necessitate that family members also consider confirmatory testing. The overarching aim is to ensure that both the patient and their family are equipped with the knowledge and resources to navigate any future medical scenarios safely.

Free lesson

This lesson is part of “Malignant Hyperthermia: Unmasking the Invisible Threat”

Lesson 15 of 19

Unlock all 19 lessons, the quiz, and 1.5 Class A credits. 1.5 of those count toward pharmacology.

More free lessons from this module